English Archives - Page 20 of 21

Lifecare and Digital Diagnostics – New 5 minute coronavirus test delivers clear results on infection

April 21, 2020
Lifecare AS (LIFE-ME) has a 25% ownership in Digital Diagnostics AG, who is now developing a New 5 minute coronavirus test which delivers clear results on infection. Lifecare AS has previously established a joint venture with Digital Diagnostics AG in Germany. Digital Diagnostics (DD) will finance the remaining costs of completing the development of Lifecare’s […]
Read more

LIFE-ME: Share options for primary insiders extended exercise period.

April 1, 2020
The Board of Directors in Lifecare AS has extended the exercise period for: - 527.839 share options for Chief Operation Officer, Rune Frisvold; - 263.920 share options for Chief Scientific Officer, Andreas Pfützner, until April 1st, 2021. The options were issued December 2016 and has a strike price of NOK 0,40. This information is subject […]
Read more

Lifecare A/S (LIFE-ME) presented data at International Conference on Advanced Technology and Treatments fo …(Note: This headline has been truncated)

February 26, 2020
At the 13th International Conference on Advanced Technology and Treatments for Diabetes (ATTD) in Madrid, a key event for global scientist, leading healthcare professionals and life science decision makers, Lifecare A/S (LIFE-ME) presented a poster on its advances in the development of the Sencell Continuous Glucose monitor. The poster with the title “Miniaturization of an […]
Read more

LIFE-ME: Lifecare has filed for Pilot Evaluation on Humans of their Sencell Osmotic Sensor Technology.

February 10, 2020
Lifecare has filed for Pilot Evaluation on Humans of their Sencell Osmotic Sensor Technology. 10.02.2020, Oslo Lifecare AS, a Norwegian life-science company, announced that they have filed for Pilot Evaluation on Humans of their Sencell Osmotic Sensor Technology. The purpose of this clinical pilot study is to explore the performance of the Sencell sensor technology […]
Read more

LIFE-ME: Lifecare Engages Top International Nanotechnology Expert to serve as Scientific Advisor for the Sencell Development!

January 20, 2020
Lifecare Engages Top International Nanotechnology Expert to serve as Scientific Advisor for the Sencell Development! Lifecare AS is pleased to welcome Prof. Michael Huth, Professor for Thinlayer Physics at the Johann-Wolfgang-vom-Goethe University in Frankfurt and one of the Global International Leaders in the field of Nanosensing Technology as a new member of the Scientific Advisory […]
Read more

STATEMENT OF CLARIFICATION – Lifecare signs joint venture to develop and digitize technologies

January 17, 2020
STATEMENT OF CLARIFICATION Lifecare AS’ Board would like to clarify and substantiate the notice published on the stock exchange on 15 January 2020: Lifecare AS and IMS Capital Partners GmbH have established Digital Diagnostics AG to complete Lifecare AS’ sensor technology, Sencell. The agreement between the parties entails that IMS Capital Partners GmbH will finance […]
Read more

LIFE-ME: Lifecare signs joint venture to develop and digitize technologies

January 15, 2020
Lifecare signs joint venture to develop and digitize technologies Lifecare today announces an exciting joint venture to further develop Lifecare’s technology and digitize medical diagnostics. The joint venture with IMS Capital Partners will establish Digital Diagnostics AG, a company co-owned by IMS Capital Partners, Lifecare AS and employees. The deal will take effect from today […]
Read more

LIFE-ME: Lifecare presented business and scientific updates

December 3, 2019
Lifecare presented business and scientific updates at an investor lunch Friday November 29th at Carnegie in Oslo. The presentation can be found on the homepage of the company. The presentation is available at "https://www.lifecare.attme.dev/" (Investor Relations / Financial Reports / Presentations). Or by copying this link to your web browser: https://assets.website-files.com/5c06911a1c7f8f2556ed747f/5de43be73719a14187ec88 a5_Lifecare%20-%20Investor%20presentation%20Nov.%2029th%202019.pdf
Read more

LIFE-ME: Primær innsidere kjøper aksjer i Lifecare AS 29-11-19

November 29, 2019
Primærinnsidere kjøper aksjer i Lifecare AS. Konstantin Kloppstech, VP Technology i Lifecare AS har gjennom sitt heleide selskap Dev Medical UG kjøpt 150.000 aksjer i Lifecare AS til kurs NOK 2,10. Frank Flacke, CTO i Lifecare AS har gjennom sitt heleide selskap Flacke Consulting kjøpt 150.000 aksjer i Lifecare AS til kurs NOK 2,10. Christian […]
Read more

LIFE-ME: Lifecare tests groundbreaking technology to analyze human data and strengthens core team

November 29, 2019
Lifecare tests groundbreaking technology to analyze human data and strengthens core team 29.11.2019, Oslo – Today Lifecare AS, a Norwegian life-science company, announced that they are getting ready to test their sensing technology on human data. This is a significant advancement in the development of the solutions to address the diabetes epidemic. Lifecare AS researches […]
Read more